Wang Linhui相关文献与解析，生知库 | 链接生命科学的每一步

Zhang, Wangzheqi; Jiang, Aimin; Jia, Bin-Kui; Jin, Yuming; Chen, Yinghu; Li, Zhaoyu; Liao, Yan; Zhang, Haoling; Lin, Zhiheng; Fang, Xiao; Wang, Linhui

Human

发表日期：2026

文献求助收藏

Insights into the mechanisms of drug resistance in renal cell carcinoma: from multi-omics perspective

从多组学角度深入了解肾细胞癌的耐药机制

期刊:International Journal of Surgery

影响因子:10.1

doi:10.1097/JS9.0000000000004600

Li, Jinxin; Hu, Jiatao; Yang, Yiren; Zhang, Hanzhong; Liu, Ying; Fang, Yu; Qu, Le; Lin, Anqi; Luo, Peng; Jiang, Aimin; Wang, Linhui

Integrated spatial and single‑cell transcriptomics maps disulfidptosis in renal cell carcinoma and reveals PDLIM1 as a prognostic biomarker and potential therapeutic target

整合空间和单细胞转录组学技术绘制肾细胞癌中二硫键凋亡图谱，揭示PDLIM1作为预后生物标志物和潜在治疗靶点。

期刊:Translational Oncology

影响因子:4.1

doi:10.1016/j.tranon.2026.102765

Liu, Wenqiang; Liu, Xianglin; Yi, Juan; Tang, Zhao; Dai, Ziwen; Song, Jiaao; Chen, Tong; Wang, Jun; Wang, Jiaxuan; Jiang, Wentao; Jiang, Aimin; Wu, Zhenjie; Tang, Lifang; Jin, Yuming; Chen, Yinghu; Wang, Linhui

Construction and validation of deep learning-based pathomics signature model for predicting postoperative recurrence of patients with clear cell renal cell carcinoma

构建和验证基于深度学习的病理组学特征模型，用于预测透明细胞肾细胞癌患者术后复发

期刊:American Journal of Cancer Research

影响因子:2.9

doi:10.62347/ZCHX8002

Yang, Yiren; Li, Jinxin; Gao, Yisha; Liu, Wenqiang; Zhu, Baohua; Ding, Jie'an; Wang, Linhui; Shi, Xiaolei; Zhang, Wei

Biomaterial-Driven Integrated Therapy for Renal Cell Carcinoma: Renal Cancer Control and Kidney Injury Repair

生物材料驱动的肾细胞癌综合治疗：肾癌控制与肾损伤修复

期刊:

影响因子:

doi:10.34133/research.1188

Song, Jiaao; Zhang, Tinglin; Li, Mingmin; Liu, Wenqiang; Chen, Tong; Qiang, Huifen; Wang, Linhui; Wu, Zhenjie; Gao, Jie

Intratumoral mycobiome heterogeneity influences the tumor microenvironment and immunotherapy outcomes in renal cell carcinoma

肿瘤内真菌群落异质性影响肾细胞癌的肿瘤微环境和免疫治疗效果

期刊:Science Advances

影响因子:12.5

doi:10.1126/sciadv.adu1727

Mou, Weiming; Deng, Zhixing; Zhu, Lingxuan; Jiang, Aimin; Lin, Anqi; Xu, Liling; Deng, Gengwen; Huang, Hongsen; Guo, Zeji; Zhu, Bang; Wu, Shuqi; Yang, Tao; Wang, Lu; Liu, Zaoqu; Wei, Ting; Zhang, Jian; Cheng, Liang; Huang, Haojie; Chen, Rui; Shao, Yi; Cheng, Quan; Wang, Linhui; Yuan, Shuofeng; Luo, Peng

Single-cell sequencing technology in renal cancer: insights into tumor biology and clinical application

单细胞测序技术在肾癌中的应用：对肿瘤生物学和临床应用的深入理解

期刊:Biomarker Research

影响因子:11.5

doi:10.1186/s40364-025-00811-0

Zhang, Hanzhong; Liu, Ying; Liu, Wenqiang; Lin, Anqi; Fang, Yu; Qu, Le; Zhang, Xu; Luo, Peng; Wang, Linhui; Jiang, Aimin

Obesity Paradox in Cancer: A Complex Interplay Between Risk and Therapeutic Outcomes

癌症中的肥胖悖论：风险与治疗结果之间的复杂相互作用

期刊:MedComm

影响因子:10.7

doi:10.1002/mco2.70494

Chen, Tong; Zhai, Wenjia; Song, Jiaao; Liu, Wenqiang; Wu, Zhenjie; Yang, Fu; Wang, Linhui

Chemotherapy-induced cellular senescence promotes stemness of aggressive B-cell non-Hodgkin's lymphoma via CCR7/ARHGAP18/IKBα signaling activation

化疗诱导的细胞衰老通过激活CCR7/ARHGAP18/IKBα信号通路促进侵袭性B细胞非霍奇金淋巴瘤的干性。

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.3

doi:10.1136/jitc-2024-009356

Jiyu Wang # ,Qianshan Tao # ,Keke Huang # ,Yangyang Wang ,Linhui Hu ,Anwen Ren ,Huiping Wang ,Yang Wan ,Jinlan Li ,Liuying Yi ,Yanjie Ruan ,Zhixiang Wanyan ,Fan Wu ,Zhimin Zhai ,Chaohong Liu

Drug resistance in cancer: molecular mechanisms and emerging treatment strategies

癌症耐药性：分子机制和新兴治疗策略

期刊:Molecular Biomedicine

影响因子:10.1

doi:10.1186/s43556-025-00352-w

Li, Jinxin; Hu, Jiatao; Yang, Yiren; Zhang, Hanzhong; Liu, Ying; Fang, Yu; Qu, Le; Lin, Anqi; Luo, Peng; Jiang, Aimin; Wang, Linhui

Progress in RNA-Targeted Therapeutics for Human Diseases

RNA靶向疗法在人类疾病治疗中的进展

Insights into the mechanisms of drug resistance in renal cell carcinoma: from multi-omics perspective

从多组学角度深入了解肾细胞癌的耐药机制

Integrated spatial and single‑cell transcriptomics maps disulfidptosis in renal cell carcinoma and reveals PDLIM1 as a prognostic biomarker and potential therapeutic target

整合空间和单细胞转录组学技术绘制肾细胞癌中二硫键凋亡图谱，揭示PDLIM1作为预后生物标志物和潜在治疗靶点。

Construction and validation of deep learning-based pathomics signature model for predicting postoperative recurrence of patients with clear cell renal cell carcinoma

构建和验证基于深度学习的病理组学特征模型，用于预测透明细胞肾细胞癌患者术后复发

Biomaterial-Driven Integrated Therapy for Renal Cell Carcinoma: Renal Cancer Control and Kidney Injury Repair

生物材料驱动的肾细胞癌综合治疗：肾癌控制与肾损伤修复

Intratumoral mycobiome heterogeneity influences the tumor microenvironment and immunotherapy outcomes in renal cell carcinoma

肿瘤内真菌群落异质性影响肾细胞癌的肿瘤微环境和免疫治疗效果

Single-cell sequencing technology in renal cancer: insights into tumor biology and clinical application

单细胞测序技术在肾癌中的应用：对肿瘤生物学和临床应用的深入理解

Obesity Paradox in Cancer: A Complex Interplay Between Risk and Therapeutic Outcomes

癌症中的肥胖悖论：风险与治疗结果之间的复杂相互作用

Chemotherapy-induced cellular senescence promotes stemness of aggressive B-cell non-Hodgkin's lymphoma via CCR7/ARHGAP18/IKBα signaling activation

化疗诱导的细胞衰老通过激活CCR7/ARHGAP18/IKBα信号通路促进侵袭性B细胞非霍奇金淋巴瘤的干性。

Drug resistance in cancer: molecular mechanisms and emerging treatment strategies

癌症耐药性：分子机制和新兴治疗策略